Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
• In patients with advanced myeloma to assess the efficacy of PXD101 treatment (as measured by response rate (CR, PR, MR, NC/SD, PD) using the response criteria of Bladé et al Br.J.Haematol. 1998, 102: 1115-23)).
Critère d'inclusion
- Patients in relapse from prior treatment, with histologically and otherwise verified diagnosis of multiple myeloma